Search

Author/Creator Fantini, Damiano

1. Antibody targeting of B7-H4 enhances the immune response in urothelial carcinoma. (1st January 2020)

Authors:
Podojil, Joseph R.; Glaser, Alexander P.; Baker, Dylan; Courtois, Elise T.; Fantini, Damiano; Yu, Yanni; Eaton, Valerie; Sivajothi, Santhosh; Chiang, Mingyi; Das, Arighno; McLaughlin, Kimberly A.; Robson, Paul; Miller, Stephen D.; Meeks, Joshua J.
Journal:
Oncoimmunology
Issue:
Volume 9:Number 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways. Issue 1 (9th October 2020)

Authors:
Dörner, Thomas; Tanaka, Yoshiya; Petri, Michelle A; Smolen, Josef S; Wallace, Daniel J; Dow, Ernst R; Higgs, Richard E; Rocha, Guilherme; Crowe, Brenda; Benschop, Robert J; Byers, Nicole L; Silk, Maria E; de Bono, Stephanie; Fantini, Damiano; Hoffman, Robert W
Journal:
Lupus science & medicine
Issue:
Volume 7:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways. Issue 1 (9th October 2020)

Authors:
Dörner, Thomas; Tanaka, Yoshiya; Petri, Michelle A; Smolen, Josef S; Wallace, Daniel J; Dow, Ernst R; Higgs, Richard E; Rocha, Guilherme; Crowe, Brenda; Benschop, Robert J; Byers, Nicole L; Silk, Maria E; de Bono, Stephanie; Fantini, Damiano; Hoffman, Robert W
Journal:
Lupus science & medicine
Issue:
Volume 7:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways. Issue 1 (9th October 2020)

Authors:
Dörner, Thomas; Tanaka, Yoshiya; Petri, Michelle A; Smolen, Josef S; Wallace, Daniel J; Dow, Ernst R; Higgs, Richard E; Rocha, Guilherme; Crowe, Brenda; Benschop, Robert J; Byers, Nicole L; Silk, Maria E; de Bono, Stephanie; Fantini, Damiano; Hoffman, Robert W
Journal:
Lupus science & medicine
Issue:
Volume 7:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways. Issue 1 (9th October 2020)

Authors:
Dörner, Thomas; Tanaka, Yoshiya; Petri, Michelle A; Smolen, Josef S; Wallace, Daniel J; Dow, Ernst R; Higgs, Richard E; Rocha, Guilherme; Crowe, Brenda; Benschop, Robert J; Byers, Nicole L; Silk, Maria E; de Bono, Stephanie; Fantini, Damiano; Hoffman, Robert W
Journal:
Lupus science & medicine
Issue:
Volume 7:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways. Issue 1 (9th October 2020)

Authors:
Dörner, Thomas; Tanaka, Yoshiya; Petri, Michelle A; Smolen, Josef S; Wallace, Daniel J; Dow, Ernst R; Higgs, Richard E; Rocha, Guilherme; Crowe, Brenda; Benschop, Robert J; Byers, Nicole L; Silk, Maria E; de Bono, Stephanie; Fantini, Damiano; Hoffman, Robert W
Journal:
Lupus science & medicine
Issue:
Volume 7:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways. Issue 1 (9th October 2020)

Authors:
Dörner, Thomas; Tanaka, Yoshiya; Petri, Michelle A; Smolen, Josef S; Wallace, Daniel J; Dow, Ernst R; Higgs, Richard E; Rocha, Guilherme; Crowe, Brenda; Benschop, Robert J; Byers, Nicole L; Silk, Maria E; de Bono, Stephanie; Fantini, Damiano; Hoffman, Robert W
Journal:
Lupus science & medicine
Issue:
Volume 7:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways. Issue 1 (9th October 2020)

Authors:
Dörner, Thomas; Tanaka, Yoshiya; Petri, Michelle A; Smolen, Josef S; Wallace, Daniel J; Dow, Ernst R; Higgs, Richard E; Rocha, Guilherme; Crowe, Brenda; Benschop, Robert J; Byers, Nicole L; Silk, Maria E; de Bono, Stephanie; Fantini, Damiano; Hoffman, Robert W
Journal:
Lupus science & medicine
Issue:
Volume 7:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways. Issue 1 (9th October 2020)

Authors:
Dörner, Thomas; Tanaka, Yoshiya; Petri, Michelle A; Smolen, Josef S; Wallace, Daniel J; Dow, Ernst R; Higgs, Richard E; Rocha, Guilherme; Crowe, Brenda; Benschop, Robert J; Byers, Nicole L; Silk, Maria E; de Bono, Stephanie; Fantini, Damiano; Hoffman, Robert W
Journal:
Lupus science & medicine
Issue:
Volume 7:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways. Issue 1 (9th October 2020)

Authors:
Dörner, Thomas; Tanaka, Yoshiya; Petri, Michelle A; Smolen, Josef S; Wallace, Daniel J; Dow, Ernst R; Higgs, Richard E; Rocha, Guilherme; Crowe, Brenda; Benschop, Robert J; Byers, Nicole L; Silk, Maria E; de Bono, Stephanie; Fantini, Damiano; Hoffman, Robert W
Journal:
Lupus science & medicine
Issue:
Volume 7:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗